AAAAAA

   
Results: 1-10 |
Results: 10
CLONAL ORIGIN OF MULTIPLE LUNG CANCERS - K-RAS AND P53 MUTATIONS DETERMINED BY NONRADIOISOTOPIC SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS
Authors: LAU DHM YANG BJ HU RD BENFIELD JR
Citation: Dhm. Lau et al., CLONAL ORIGIN OF MULTIPLE LUNG CANCERS - K-RAS AND P53 MUTATIONS DETERMINED BY NONRADIOISOTOPIC SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS, Diagnostic molecular pathology, 6(4), 1997, pp. 179-184
CONCURRENT CARBOPLATIN, ETOPOSIDE AND THORACIC RADIATION FOR POOR-RISK STAGE-III NON-SMALL-CELL LUNG-CARCINOMA - A PILOT-STUDY
Authors: LAU DHM RYU JK GANDARA DR ROSENTHAL SA
Citation: Dhm. Lau et al., CONCURRENT CARBOPLATIN, ETOPOSIDE AND THORACIC RADIATION FOR POOR-RISK STAGE-III NON-SMALL-CELL LUNG-CARCINOMA - A PILOT-STUDY, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 157-161
PHASE-II TRIAL OF EDATREXATE PLUS CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: GANDARA DR EDELMAN MJ CROWLEY JJ LAU DHM LIVINGSTON RB
Citation: Dr. Gandara et al., PHASE-II TRIAL OF EDATREXATE PLUS CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 75-78
TWICE-WEEKLY PACLITAXEL AND RADIATION FOR STAGE-III NONSMALL CELL LUNG-CANCER
Authors: LAU DHM RYU JK GANDARA DR MORGAN R DOROSHOW J WILDER R LEIGH B
Citation: Dhm. Lau et al., TWICE-WEEKLY PACLITAXEL AND RADIATION FOR STAGE-III NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 106-109
CHEMORADIOTHERAPY FOR POOR-RISK STAGE-III NONSMALL CELL LUNG-CANCER
Authors: LAU DHM RYU JK GANDARA DR
Citation: Dhm. Lau et al., CHEMORADIOTHERAPY FOR POOR-RISK STAGE-III NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 110-112
THE PRICE OF REMISSION
Authors: ALJAZAYRLY G LAU DHM
Citation: G. Aljazayrly et Dhm. Lau, THE PRICE OF REMISSION, Western journal of medicine, 166(3), 1997, pp. 225-225
DIFFERENTIAL SINGLE-STRAND VERSUS DOUBLE-STRAND DNA BREAKAGE PRODUCEDBY DOXORUBICIN AND ITS MORPHOLINYL ANALOGS
Authors: DURAN GE LAU DHM LEWIS AD KUHL JS BAMMLER TK SIKIC BI
Citation: Ge. Duran et al., DIFFERENTIAL SINGLE-STRAND VERSUS DOUBLE-STRAND DNA BREAKAGE PRODUCEDBY DOXORUBICIN AND ITS MORPHOLINYL ANALOGS, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 210-216
LOSS OF NM23 AND ALU DNA IN HUMAN LUNG-CANCER PROPAGATED IN NUDE-MICE
Authors: LAU DHM LU D HAMMOND WG SCHMID CW BENFIELD JR
Citation: Dhm. Lau et al., LOSS OF NM23 AND ALU DNA IN HUMAN LUNG-CANCER PROPAGATED IN NUDE-MICE, Cancer letters, 97(2), 1995, pp. 163-168
ANALYSIS OF INTRACELLULAR RETENTION OF MORPHOLINYL ANTHRACYCLINES IN MULTIDRUG-RESISTANT CANCER-CELLS BY INTERACTIVE LASER CYTOMETRY
Authors: LAU DHM DURAN GE SIKIC BI
Citation: Dhm. Lau et al., ANALYSIS OF INTRACELLULAR RETENTION OF MORPHOLINYL ANTHRACYCLINES IN MULTIDRUG-RESISTANT CANCER-CELLS BY INTERACTIVE LASER CYTOMETRY, International journal of oncology, 5(6), 1994, pp. 1273-1277
METABOLIC CONVERSION OF METHOXYMORPHOLINYL DOXORUBICIN - FROM A DNA STRAND BREAKER TO A DNA CROSS-LINKER
Authors: LAU DHM DURAN GE LEWIS AD SIKIC BI
Citation: Dhm. Lau et al., METABOLIC CONVERSION OF METHOXYMORPHOLINYL DOXORUBICIN - FROM A DNA STRAND BREAKER TO A DNA CROSS-LINKER, British Journal of Cancer, 70(1), 1994, pp. 79-84
Risultati: 1-10 |